Endoflip EF-301-RFB
by Covidien LP
Endoflip EF-301-RFB is a medical device (FDA Class II; FDA product code FFX, System, Gastrointestinal Motility (Electrical)) made by Covidien LP, cleared under FDA 510(k) K231861 on 21 Jul 2023 and listed in FDA GUDID since 12 Apr 2024 (UDI-DI 10884521833869), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number10884521833869 | Date12 Apr 2024 | StatusListed |
| United States | FDA 510(k)SESE | NumberK231861 | Date21 Jul 2023 | StatusActive |
Official records
- AccessGUDID record 10884521833869
- FDA 510(k) database K231861
From the FDA record
- Device description
- Refurbished 300 Pump System With Pre-Use Tube
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K231861 decided 21 Jul 2023 Active
- FDA GUDID UDI-DI 10884521833869 listed 12 Apr 2024 Listed
Timeline
- Cleared FDA 510(k) K231861
- Listed FDA GUDID 10884521833869
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Endoflip
- Generic name
- Manometric gastrointestinal motility analysis system
- Model / reference
- EF-301-RFB
- Primary DI / UDI-DI
- 10884521833869
- 510(k) Number
- FDA product code
- FFX
- GMDN term
- Manometric gastrointestinal motility analysis system
- Device class
- Class II
- Regulation number
- 876.1725
- GUDID distribution status
- In Commercial Distribution